StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research note issued to investors on Sunday. The firm issued a hold rating on the medical research company’s stock. Several other equities analysts have also issued reports on CTSO. B. Riley reissued a buy rating and set a $3.00 target price on […]